£520.00

It has never been this cheap. We have no record of a lower price.

£520 today · cheaper than every other day in the last 3 months

The 2023-2028 Outlook for Platelet Rich Plasma in the United States

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 37 days · 37 data points (no recent data)

Historical
Generating forecast…
£520.00 £494.00 £504.40 £514.80 £525.20 £535.60 £546.00 22 August 2026 31 August 2026 09 September 2026 18 September 2026 27 September 2026
View at Amazon ↗

Price data last checked 54 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 37 days • 1 price levels

Days at Price
37 days 0 9 19 28 37 £520 Days at Price

Price Analysis

Most common price: £520 (37 days, 100.0%)

Price range: £520 - £520

Price levels: 1 different prices over 37 days

Description

This study covers the latent demand outlook for platelet rich plasma across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across some 12,600 cities in the United States. For each city in question, the percent share the city is of its state and of the United States as a whole is reported. These comparative benchmarks allow the reader to quickly gauge a city vis-à-vis others. This statistical approach can prove very useful to distribution and/or sales force strategies. Using econometric models which project fundamental economic dynamics within each state and city, latent demand estimates are created for platelet rich plasma. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. In this report we define the sales of platelet rich plasma as including all commonly understood products and/or services falling within this broad category, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include AdiStem, Arteriocyte Medical Systems, Arthrex Inc (U.S.)., Biomet, Biotest, CellMedix Holdings, LLC (U.S.), Cesca Therapeutics, China Biologic Products, CSL Ltd.( Australia), DePuy Synthes, Dr. PRP America, EmCyte, Exactech, Glofinn, Harvest Technologies, ISTO Biologics, Nuo Therapeutics, Regen Lab, Stryker, T-Biotechnology, Terumo BCT, and Zimmer Biomet. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2022).

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
26 October 2022
Listed Since
11 November 2022

Similar Products You Might Like

The 2023-2028 Outlook for Blood Transfusion in the United States
89% match

The 2023-2028 Outlook for Blood Transfusion in the United States

£520.00 27 Sep 2026
The 2023-2028 Outlook for Upper Extremities Treatment Products in the United States
89% match

The 2023-2028 Outlook for Upper Extremities Treatment Products in the United States

£520.00 27 Sep 2026
The 2023-2028 Outlook for Biologic Vasculitis Treatments in the United States
88% match

The 2023-2028 Outlook for Biologic Vasculitis Treatments in the United States

£520.00 27 Sep 2026
The 2023-2028 World Outlook for Spine Biologics
88% match

The 2023-2028 World Outlook for Spine Biologics

£795.00 15 Sep 2026
The 2023-2028 Outlook for Interventional Radiology in the United States
88% match

The 2023-2028 Outlook for Interventional Radiology in the United States

£520.00 27 Sep 2026
The 2023-2028 Outlook for Blood Products in India
88% match

The 2023-2028 Outlook for Blood Products in India

£515.00 27 Sep 2026
The 2023-2028 Outlook for Blood Testing in India
87% match

The 2023-2028 Outlook for Blood Testing in India

£515.00 27 Sep 2026
The 2023-2028 Outlook for Disposable Conventional Syringes in the United States
87% match

The 2023-2028 Outlook for Disposable Conventional Syringes in the United States

£520.00 27 Sep 2026
The 2023-2028 Outlook for Bone Marrow Autologous Cell Therapies for US Zip Codes
87% match

The 2023-2028 Outlook for Bone Marrow Autologous Cell Therapies for US Zip Codes

£490.00 27 Sep 2026
The 2023-2028 World Outlook for Growth Factors (Blood and Tissue)
87% match

The 2023-2028 World Outlook for Growth Factors (Blood and Tissue)

£795.00 15 Sep 2026
The 2023-2028 Outlook for Aesthetic Medicines in the United States
87% match

The 2023-2028 Outlook for Aesthetic Medicines in the United States

£520.00 27 Sep 2026
The 2026-2031 World Outlook for Cold Plasma Treatment of Textiles
87% match

The 2026-2031 World Outlook for Cold Plasma Treatment of Textiles

£885.00 22 Sep 2026
The 2023-2028 Outlook for Proliferative Diabetic Retinopathy Treatments in India
87% match

The 2023-2028 Outlook for Proliferative Diabetic Retinopathy Treatments in India

£515.00 27 Sep 2026
The 2023-2028 Outlook for Renal Anemia Treatments in the United States
87% match

The 2023-2028 Outlook for Renal Anemia Treatments in the United States

£520.00 27 Sep 2026
The 2023-2028 Outlook for Laser Hair Removal in the United States
87% match

The 2023-2028 Outlook for Laser Hair Removal in the United States

£520.00 27 Sep 2026
The 2023-2028 Outlook for Hepatitis Therapeutics in the United States
87% match

The 2023-2028 Outlook for Hepatitis Therapeutics in the United States

£520.00 27 Sep 2026
The 2023-2028 Outlook for Wound Dressing Products in the United States
87% match

The 2023-2028 Outlook for Wound Dressing Products in the United States

£520.00 27 Sep 2026
2027-2032 World Outlook for Bioprinting - Market Analysis
86% match

2027-2032 World Outlook for Bioprinting - Market Analysis

£890.00 28 Sep 2026
The 2023-2028 Outlook for Biologic Vasculitis Treatments in India
86% match

The 2023-2028 Outlook for Biologic Vasculitis Treatments in India

£515.00 27 Sep 2026
The 2023-2028 Outlook for Aesthetic Laser and Energy Devices in the United States
86% match

The 2023-2028 Outlook for Aesthetic Laser and Energy Devices in the United States

£520.00 27 Sep 2026
The 2023-2028 Outlook for Autologous Stem Cell and Non-Stem Cell Based Therapies for US Zip Codes
86% match

The 2023-2028 Outlook for Autologous Stem Cell and Non-Stem Cell Based Therapies for US Zip Codes

£490.00 27 Sep 2026
The 2023-2028 Outlook for Laser Hair Loss Treatments in the United States
86% match

The 2023-2028 Outlook for Laser Hair Loss Treatments in the United States

£520.00 27 Sep 2026
The 2023-2028 Outlook for Wound Dressings in the United States
86% match

The 2023-2028 Outlook for Wound Dressings in the United States

£520.00 27 Sep 2026
The 2023-2028 Outlook for HIV-AIDS Immunoassay Diagnostics in the United States
86% match

The 2023-2028 Outlook for HIV-AIDS Immunoassay Diagnostics in the United States

£520.00 27 Sep 2026